ArticleStroke and vascular neurology2025

Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOtor deficits (MAESTOSO) study protocol.

Christopher P L H Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.